.jpg?format=webp&quality=80&width=3840)
A study sheds light on predicting pharmacotherapy needs for chronic kidney disease (CKD) patients. Conducted on 2196 CKD stage G4/G5 patients, the study identified predictive variables—including age, diabetes status, and various laboratory parameters—for the future use of vitamin D receptor agonists (VDRA), phosphate binders, erythropoiesis-stimulating agents (ESAs), and iron. Results indicated potential reductions in follow-up frequency for patients with lower risk profiles, emphasizing personalized care in CKD management.
Like
Save
Share